Sunshield Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve In furtherance to our intimation dated July 18, 2025 regarding the Board Meeting of the Company scheduled on July 31, 2025, to consider and approve, inter alia, the Unaudited Financial Results of the Company for the quarter ended June 30, 2025, please note that the Board in the said meeting shall also consider the following proposal: 1. Withdraw the Draft Letter of Offer dated September 30, 2024, filed with SEBI under the erstwhile SEBI regulations applicable for Rights Issues; and 2. Supersede the Board meeting approval dated 9 August 2024 for the Rights Issue and pass a fresh resolution approving the proposal i.e. fund raising by way of a rights issue to the eligible equity shareholders of the Company, to avail the benefit and pursue the proposed rights issue under the Amended Rights Issue Regulations, as permitted under applicable laws and subject to receipt of regulatory/ necessary approvals, as may be required.